Wikidata

(Q50972210)

English

A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma.

scientific article published on 25 January 2012

In more languages
default values for all languages
No label defined

No description defined

Statements

title
A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22277052
retrieved
26 March 2018
reference URL
http://europepmc.org/abstract/MED/22277052

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q50972210&oldid=2211879804"